These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 441472

  • 1. [Results of 5-fluorouracil, methotrexate, cyclophosphamide and prednisone combination therapy in the treatment of advanced breast cancer].
    García Puche JL, Ballesteros P, Cueto J, Mendiola C, Rodríguez PA, Talavera MC.
    Rev Clin Esp; 1979 Feb 15; 152(3):203-8. PubMed ID: 441472
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of advanced breast cancer with cyclophosphamide, methotrexate, 5-fluorouracil and prednisone (CMFP)].
    Rabinovich MG, Leone BA, Landó O.
    Medicina (B Aires); 1981 Feb 15; 41(1):65-70. PubMed ID: 7266359
    [No Abstract] [Full Text] [Related]

  • 3. [Combination chemotherapy in advanced carcinoma of the breast].
    Carmo-Pereira J, Galvão-Teles A, Oliveira Costa F, Bak Gordon R, Henriques E, Dória JM, Freire Cruz M, Silveira Botelho L.
    Arq Patol; 1974 Feb 15; 46(2-3):309-23. PubMed ID: 4458643
    [No Abstract] [Full Text] [Related]

  • 4. CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women.
    Salimtschik M, Snel S, Havsteen H, Dombernowsky P, Mouridsen HT.
    Cancer Treat Rep; 1980 Feb 15; 64(4-5):635-7. PubMed ID: 7000346
    [Abstract] [Full Text] [Related]

  • 5. [Results of "5-drug" treatment of advanced breast cancer].
    Dorociak R.
    Pol Tyg Lek; 1981 Sep 21; 36(38):1467-70. PubMed ID: 7329862
    [No Abstract] [Full Text] [Related]

  • 6. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
    Lee JM, Abeloff MD, Lenhard RE, Baker RR.
    Surg Gynecol Obstet; 1974 Jan 21; 138(1):77-80. PubMed ID: 4809006
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].
    Pérez JE, Machiavelli M, Romero A, Leone BA, Rabinovich MG, Arévalo E.
    Medicina (B Aires); 1982 Jan 21; 42(6 Pt 1):587-95. PubMed ID: 6897849
    [No Abstract] [Full Text] [Related]

  • 8. Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer.
    Chang YC, Falkson G, Tormey DC, Crowley J.
    Cancer Clin Trials; 1981 Jan 21; 4(4):377-80. PubMed ID: 6797746
    [Abstract] [Full Text] [Related]

  • 9. Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
    Cowan K, Lippman M.
    Arch Intern Med; 1981 Jul 21; 141(8):1055-9. PubMed ID: 7018440
    [No Abstract] [Full Text] [Related]

  • 10. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
    Heuson JC, Paridaens R.
    Rev Med Brux; 1982 Apr 21; 3(4):209-16. PubMed ID: 7046007
    [No Abstract] [Full Text] [Related]

  • 11. Combination chemotherapy for disseminated carcinoma of the breast.
    Lozada JA, Grillo-López A, Vélez-Garciá E.
    Bol Asoc Med P R; 1975 Jun 21; 67(6):157-63. PubMed ID: 1055588
    [No Abstract] [Full Text] [Related]

  • 12. [Polychemotherapy of advanced cancer of the breast].
    Mascia V, Massidda B, Pellegrini A.
    Minerva Med; 1978 May 26; 69(26):1803-8. PubMed ID: 662182
    [Abstract] [Full Text] [Related]

  • 13. Combination chemotherapy in disseminated carcinoma of the breast.
    Kaufman S, Goldstein M.
    Surg Gynecol Obstet; 1973 Jul 26; 137(1):83-6. PubMed ID: 4714324
    [No Abstract] [Full Text] [Related]

  • 14. [Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy].
    Mouridsen HT, Palshof T, Brahm M, Rahbek I.
    Ugeskr Laeger; 1977 Oct 31; 139(44):2632-5. PubMed ID: 929742
    [No Abstract] [Full Text] [Related]

  • 15. Prospective evaluation of rotating chemotherapy in advanced breast cancer. An Eastern Cooperative Oncology Group Trial.
    Tormey D, Gelman R, Falkson G.
    Am J Clin Oncol; 1983 Feb 31; 6(1):1-18. PubMed ID: 6340458
    [No Abstract] [Full Text] [Related]

  • 16. Chemotherapy for breast cancer.
    Sarg MJ.
    J Reprod Med; 1979 Jul 31; 23(1):3-11. PubMed ID: 226698
    [No Abstract] [Full Text] [Related]

  • 17. Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast.
    Smalley RV, Murphy S, Huguley CM, Bartolucci AA.
    Cancer Res; 1976 Nov 31; 36(11 Pt 1):3911-6. PubMed ID: 975039
    [Abstract] [Full Text] [Related]

  • 18. Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer.
    Cadman EC, Glick JH, Cross J, Horton J, Taylor SG.
    Cancer Treat Rep; 1984 Jun 31; 68(6):877-9. PubMed ID: 6547367
    [Abstract] [Full Text] [Related]

  • 19. Editorial: Major advance in breast-cancer therapy.
    Holland JF.
    N Engl J Med; 1976 Feb 19; 294(8):440-1. PubMed ID: 1246311
    [No Abstract] [Full Text] [Related]

  • 20. [Cytostatic combination therapy in metastatic breast cancer].
    Mouridsen HT.
    Ugeskr Laeger; 1973 Jun 18; 135(25):1336-40. PubMed ID: 4757127
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.